CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
followed by maintenance durvalumab and bevacizumab or durvalumab, bevacizumab and olaparib in patients with newly diagnosed advanced ovarian ...
Phase 3
Salt Lake City, Utah, United States and 213 other locations
This study will assess the safety and efficacy of avutometinib (VS-6766) in combination with defactinib versus Investigator's choice of treatments (I...
Phase 3
Murray, Utah, United States and 50 other locations
to the enrollment of patients diagnosed with triple-negative breast cancer or ovarian cancer. Dose expansion will only be ...
Phase 1
Salt Lake City, Utah, United States and 1 other location
To evaluate the efficacy of romiplostim for the treatment of CIT in patients receiving chemotherapy for the treatment of NSCLC, ovarian cancer...
Phase 3
Ogden, Utah, United States of America and 128 other locations
Ovarian cancer is a heterogeneous disease, characterized by complex molecular and genetic changes. The high expression of vascular ...
Phase 3
Ogden, Utah, United States and 202 other locations
This study will test the safety, including side effects, and determine the characteristics of a drug called PRO1184 in participants with solid tumors...
Phase 1, Phase 2
West Valley City, Utah, United States of America and 31 other locations
This study aims to assess efficacy of Niraparib (GSK3985771) as maintenance treatment in participants with Stage III or IV ovarian cancer...
Phase 3
Salt Lake City, Utah, United States and 196 other locations
ecteribulin (MORAb-202) and compare it to Investigator's choice (IC) chemotherapy in female participants with platinum-resistant HGS ovarian....
Phase 2
Salt Lake City, Utah, United States and 82 other locations
following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...
Phase 3
Salt Lake City, Utah, United States and 237 other locations
preliminary antitumor activity of NKT3447 in adult subjects with cyclin E1 (CCNE1) amplified ovarian cancer at the RDEs selected i...
Phase 1
West Valley City, Utah, United States of America and 7 other locations
Clinical trials
Research sites
Resources
Legal